Edgestream Partners’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.92M | Buy |
+44,556
| New | +$1.92M | 0.05% | 534 |
|
|
2025
Q1 | – | Sell |
-56,235
| Closed | -$1.54M | – | 843 |
|
|
2024
Q4 | $1.54M | Buy |
+56,235
| New | +$1.54M | 0.07% | 456 |
|
|
2024
Q2 | – | Sell |
-43,115
| Closed | -$1.33M | – | 848 |
|
|
2024
Q1 | $1.33M | Sell |
43,115
-7,187
| -14% | -$222K | 0.07% | 438 |
|
|
2023
Q4 | $2.03M | Buy |
50,302
+35,262
| +234% | +$1.42M | 0.15% | 234 |
|
|
2023
Q3 | $397K | Buy |
15,040
+598
| +4% | +$15.8K | 0.03% | 644 |
|
|
2023
Q2 | $248K | Buy |
+14,442
| New | +$248K | 0.02% | 657 |
|